ZA859645B - Theophylline sustained release formulation - Google Patents
Theophylline sustained release formulationInfo
- Publication number
- ZA859645B ZA859645B ZA859645A ZA859645A ZA859645B ZA 859645 B ZA859645 B ZA 859645B ZA 859645 A ZA859645 A ZA 859645A ZA 859645 A ZA859645 A ZA 859645A ZA 859645 B ZA859645 B ZA 859645B
- Authority
- ZA
- South Africa
- Prior art keywords
- sustained release
- release formulation
- theophylline sustained
- theophylline
- formulation
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH611184 | 1984-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA859645B true ZA859645B (en) | 1986-08-27 |
Family
ID=4304441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA859645A ZA859645B (en) | 1984-12-21 | 1985-12-18 | Theophylline sustained release formulation |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS61152629A (zh) |
ZA (1) | ZA859645B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8628728D0 (en) * | 1986-12-02 | 1987-01-07 | Euro Celtique Sa | Spheroids |
-
1985
- 1985-12-18 ZA ZA859645A patent/ZA859645B/xx unknown
- 1985-12-19 JP JP60284508A patent/JPS61152629A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
Also Published As
Publication number | Publication date |
---|---|
JPH0474331B2 (zh) | 1992-11-26 |
JPS61152629A (ja) | 1986-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2207353B (en) | Controlled release formulation | |
EP0187703A3 (en) | Sustained release preparation | |
NZ214534A (en) | Sustained release formulation containing theophylline | |
GB8426922D0 (en) | Galenic formulation | |
GB8727590D0 (en) | Formulation | |
GB8428952D0 (en) | Formulations | |
GB8712251D0 (en) | Formulation | |
ZA859645B (en) | Theophylline sustained release formulation | |
GB2207864B (en) | Antiviral composition comprising isopropyldeoxyuridine | |
GB8521221D0 (en) | Controlled release formulations | |
IE840461L (en) | Controlled release formulation comprising a¹triazolobenzothiazole | |
EG17797A (en) | Controlled release formulation | |
GB8720608D0 (en) | Formulation | |
GB8714838D0 (en) | Formulation | |
GB8713878D0 (en) | Formulation | |
GB8713818D0 (en) | Formulation | |
GB8720784D0 (en) | Formulation | |
GB8729672D0 (en) | Formulation | |
GB8730115D0 (en) | Formulation | |
GB8706242D0 (en) | Formulation | |
GB8406326D0 (en) | Formulation | |
GB8425313D0 (en) | Formulation | |
IE860577L (en) | Sustained release composition | |
GB8606259D0 (en) | Formulation | |
GB8614980D0 (en) | Formulation |